BCMA CAR T cells Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

University College, London1
Chongqing Precision Biotech Co., Ltd1

Indications

Multiple Myeloma2
Cancer2
Neoplasm, Plasma Cell1
Multiple Myeloma in Relapse1

Other2 trials

A New Study Evaluating the Activity of Modular CAR T for mYeloma

Phase 1

BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.